Aprocitentan in Patients With CKD and Resistant Hypertension ca. 2026
#Nephpearls #NephSky
ā Well tolerated
ā Lowered BP (nighttime ambulatory BP)
ā Markedly reduced urine albumin-to-creatinine ratio (UACR) in participants w/ CKD and resistant hypertension
š pubmed.ncbi.nlm.nih.gov/41363010/